Is sarcoidosis associated with increased occurrence of malignancy? A retrospective analysis

M. Doubkova, I. Binkova, J. Skrickova (Brno, Czech Republic)

Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders
Session: Different profiles of sarcoidosis and other granulomatous disorders
Session type: Thematic Poster Session
Number: 3730
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Doubkova, I. Binkova, J. Skrickova (Brno, Czech Republic). Is sarcoidosis associated with increased occurrence of malignancy? A retrospective analysis. Eur Respir J 2011; 38: Suppl. 55, 3730

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Presence of concurrent sarcoid-like granulomas indicates better survival in cancer patients: a retrospective cohort study
Source: ERJ Open Res, 6 (4) 00061-2020; 10.1183/23120541.00061-2020
Year: 2020



Sinonasal involvement is a severe manifestation of sarcoidosis: a case-control study of 20 patients
Source: Eur Respir J 2002; 20: Suppl. 38, 435s
Year: 2002

Nutrition-related factors associated with waiting list mortality in patients with interstitial lung disease: a retrospective cohort study
Source: International Congress 2019 – Lung transplantation: from bench to bedside
Year: 2019


Predicting factors for sarcoidosis outcome: retrospective cohort study
Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Year: 2019

The comparison of sarcoidosis patients with benign and recurrent clinical course of the disease
Source: Eur Respir J 2005; 26: Suppl. 49, 331s
Year: 2005

Interstitial lung disease associated with ANCA positivity: a retrospective analysis
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019

Prognostic significance of pathologically proven chronic fibrosing interstitial lung diseases with a progressive phenotype (PF-ILDs): single center retrospective cohort
Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020


A retrospective study of the cause and impact of delayed diagnosis of lung cancer (LC)
Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology
Year: 2008

Seasonality of hypercalcemia - A population-based study on patients with pulmonary sarcoidosis
Source: Virtual Congress 2021 – Moving forward in various aspects of sarcoidosis
Year: 2021


Clinical features and short-term outcomes of cancer patients with suspected and unsuspected pulmonary embolism: the EPIPHANY study
Source: Eur Respir J 2017; 49(1): 1600282; DOI: 10.1183/13993003.00282-2016
Year: 2017



Sarcoidosis and malignancy. Retrospective study of 6 clinical cases and literature review
Source: Annual Congress 2010 - Management of sarcoidosis and lung manifestations of systemic diseases
Year: 2010

Genome-wide association analysis reveals 12q13.3–q14.1 as new risk locus for sarcoidosis
Source: Eur Respir J 2013; 41: 888-900
Year: 2013



Prevalence and characteristics of self-reported hypothyroidism and its association with nonorgan-specific manifestations in US sarcoidosis patients: a nationwide registry study
Source: ERJ Open Res, 7 (1) 00754-2020; 10.1183/23120541.00754-2020
Year: 2021



Comparative survival analysis between idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis: Retrospective cohort study.
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis:  mechanistic insights and prognostic markers
Year: 2018


Late Breaking Abstract - A composite serum biomarker index for the diagnosis of systemic sclerosis associated interstitial lung disease: a multicentre, observational, cohort study
Source: Virtual Congress 2021 – New approaches to diagnostic and prognostic evaluation of interstitial lung diseases of known causes
Year: 2021



Variables associated with functional improvement in patients with interstitial lung disease and myositis related antibodies: Results from a multicentric Latin American study.
Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new?
Year: 2019


A retrospective analysis of the outcomes of patients presenting with central pulmonary embolism
Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease and other pulmonary vascular disorders
Year: 2010


Follow-up of the patients with newly diagnosed sarcoidosis treated with oral corticosteroids. Features associated with chronic sarcoidosis
Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases
Year: 2008

Performing follow up chest x-rays for patients with a recent pneumonia leads to a significant number of other malignant and non-malignant pathologies being diagnosed.
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020


Risk factors for cardiac involvement in sarcoidosis - A case-control study in 201 Caucasian patients
Source: International Congress 2016 – Sarcoidosis
Year: 2016